POLYGON THERAPEUTICS
Business purpose.
Toutes opérations de recherche, de développement d'études scientifiques et techniques portant sur des produits de santé et à l'acquisition ou la cession sous toutes leurs formes de droits de propriété intellectuelle y afférent.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- 6 to 9 employees
- Created
- 20 Jan 2021
- Share capital
- 16,431.90 EUR
- Registered with the trade register
- 22 Jan 2021
- Financial year end
- 31/12
- Establishments
- 5
Directors
- TATIANA MARIE GINETTE MONSEUR 34 years old, 09/1992 Directeur general
- Mohamed Abou Ali 32 years old, 07/1994 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- POLYGON HOLDING via Mohamed Abou Ali
Establishments
-
89322166300022 75006 PARIS
-
89322166300030 75015 PARIS
-
89322166300048 75015 PARIS
-
89322166300055 75009 PARIS
Financial strength
Financial score
48 / 100 D
Confidence: medium · computed on the financial year ended 31 Dec 2025
- Equity to assets (32.7 %)
- 13.1 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (243.8 %)
- 10.6 out of 20
- Debt (84.4 %)
- 7.7 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
91 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (5.7 years)
- 11.5 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2025 | 0 € | — | 0 € | -938,199 € |
| 31 Dec 2024 | 0 € | — | 0 € | -1,707,869 € |
| 31 Dec 2023 | 0 € | — | 0 € | -388,571 € |
| 31 Dec 2022 | 0 € | first year on record | 0 € | -324,857 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.
IDCC 0176 · repealed · 1 establishment · declared in July 2026
Legal notices
-
Filing of accounts 23 Jun 2026
- Court :
- Greffe du Tribunal des Activités Economiques de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260117, annonce n 13301 · Proof of publication (PDF)
-
Filing of accounts 23 Sep 2025
- Court :
- Greffe du Tribunal des Activités Economiques de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250182, annonce n 11073 · Proof of publication (PDF)
-
Amendment 16 Oct 2024
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20240201, annonce n 2690 · Proof of publication (PDF)
-
Filing of accounts 10 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240132, annonce n 7241 · Proof of publication (PDF)
-
Amendment 22 Feb 2024
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20240037, annonce n 5553 · Proof of publication (PDF)
-
Filing of accounts 30 May 2023
- Court :
- Greffe du Tribunal de Commerce de nanterre
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20230103, annonce n 4532 · Proof of publication (PDF)
-
Amendment 30 Nov 2021
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20210232, annonce n 2705 · Proof of publication (PDF)
-
Incorporation 26 Jan 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE NANTERRE
BODACC A n 20210017, annonce n 3025 · Proof of publication (PDF)
Filings and accounts
- Formality 20 Feb 2025
- Formality 20 Feb 2025
- Formality 14 Feb 2025
- Formality 1 Jul 2024
- Formality 1 Jul 2024
Change history
- officer_appointed (empty) → Directeur general 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- capital 16431.90 → 10000.00 3 Oct 2026
- capital 15250.30 → 16431.90 2 Oct 2026
- capital (empty) → 15250.30 2 Oct 2026
- registered_address (empty) → 77 Rue Louis Rouquier 92300 Levallois-Perret 1 Oct 2026